CamGene Therapeutics
PrivateLast Round
Seed
Oct 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CamGene Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in October 2025.
CamGene Therapeutics is a biotechnology company developing RNA-based therapeutics designed to address the underlying cellular dysfunction that causes hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CamGene Therapeutics Comparables
Compare CamGene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rinri Therapeutics | 79% | |
| Spiral Therapeutics | 76% | |
| Suzhou Otovia Therapeutics Co., Ltd. | 71% |
For institutional investors. Book with your work email.
CamGene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2025 | ||||
| Pre Seed | Apr 5, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CamGene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Enterprise Ventures | Seed |
| o2h ventures | Seed, Pre Seed |
| UK Innovation & Science Seed Fund | Seed |
| LongRiver Investments | Seed |
| Eos Advisory | Seed |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 283% MoM.
- Mar 7, 2026
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
CamGene Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CamGene Therapeutics's valuation, stock price, and market status.
Is CamGene Therapeutics a public or private company?
CamGene Therapeutics is a private company.
What is the current stock price of CamGene Therapeutics?
CamGene Therapeutics is a private company, so its shares have no public market price. Caplight tracks CamGene Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CamGene Therapeutics worth (valuation)?
Valuation information for CamGene Therapeutics is not publicly available.
Can I buy CamGene Therapeutics stock?
CamGene Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CamGene Therapeutics's last funding round?
CamGene Therapeutics's most recent funding round was Seed on October 29, 2025.
Who are the main investors in CamGene Therapeutics?
Key investors in CamGene Therapeutics include o2h ventures, UK Innovation & Science Seed Fund.
Will CamGene Therapeutics IPO soon?
No public IPO plans have been announced for CamGene Therapeutics.
How can I track CamGene Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in CamGene Therapeutics's shares on secondary markets.